End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.66 USD | -0.51% | +3.43% | +14.32% |
May. 07 | TriSalus Life Sciences, Inc. Appoints Liselotte Hyveled to Its Board of Directors | CI |
May. 01 | TriSalus Life Sciences Obtains $50 Million Debt Facility | MT |
Financials (USD)
Sales 2024 * | 30.64M | Sales 2025 * | 48.29M | Capitalization | 262M |
---|---|---|---|---|---|
Net income 2024 * | -36M | Net income 2025 * | -29M | EV / Sales 2024 * | 8.56 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 5.43 x |
P/E ratio 2024 * |
-4.54
x | P/E ratio 2025 * |
-6.62
x | Employees | 112 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 45.6% |
Latest transcript on TriSalus Life Sciences, Inc.
1 day | -0.51% | ||
1 week | +3.43% | ||
Current month | +3.76% | ||
1 month | -1.43% | ||
3 months | -0.62% | ||
6 months | +146.43% | ||
Current year | +14.32% |
Managers | Title | Age | Since |
---|---|---|---|
Mary Szela
CEO | Chief Executive Officer | 60 | 17-12-31 |
Sean Murphy
DFI | Director of Finance/CFO | 71 | 23-08-09 |
Steven Katz
CTO | Chief Tech/Sci/R&D Officer | 49 | 23-08-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kerry Hicks
BRD | Director/Board Member | 64 | 23-08-09 |
Mats Wahlström
CHM | Chairman | 70 | 23-08-09 |
George Martin
BRD | Director/Board Member | 65 | 23-08-09 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 9.8 | +1.45% | 8,227 |
24-05-08 | 9.66 | -0.51% | 5,826 |
24-05-07 | 9.71 | +0.94% | 23,102 |
24-05-06 | 9.62 | 0.00% | 18,217 |
24-05-03 | 9.62 | +3.00% | 24,438 |
End-of-day quote Nasdaq, May 07, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.32% | 262M | |
+2.97% | 108B | |
+10.21% | 104B | |
+2.07% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-37.64% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |
- Stock Market
- Equities
- TLSI Stock